Innovative Laboratory Systems的动态

??? Could Soligenix (SNGX) be the next big winner in biotech? ?? In our latest video, we dive deep into their groundbreaking HyBryte study and explore the future potential of this innovative biopharma company. ???? Discover Soligenix's recent achievements, upcoming milestones, and why HyBryte stands out as a promising treatment in the biotech landscape. ???? Join us as we analyze the key factors that could drive Soligenix's growth and find out if SNGX stock is a smart investment for the future. ???? Watch now to get the inside scoop! ?? https://lnkd.in/dHArNM8R

Working on the General Pharma Legislation with EuropaBio - the European Association for Bioindustries team was and still is a valuable experience. ?? Proposing a revision of the #GPL after 20-year means a chance to strengthen European competitiveness in the development of cutting-edge therapies and medicines. ?? It is necessary to translate #EU market ambitions into concrete actions to reinforce the European biotech ecosystem, promoting innovation and ensuring effective and faster access to medicines. ??More #biotech innovations in the EU means more quality for EU healthcare systems. ?? If you want to read more about this: https://lnkd.in/d5Hs3f_U ?

?? Are you attending Swiss Biotech Day? Connect with our delegates to start a conversation and discover how we can assist you with our agile and holistic biotech solutions! #biotech #swissbiotechday2024 Swiss Biotech Association

Join Blake Mandell from Transcend Therapeutics at the upcoming Fierce Biotech Summit on Sept 30 - Oct 1 in Boston as he shares his expertise in groundbreaking biotech innovations and advancements. Register now and save up to $500 with the Early Bird Rate: https://ow.ly/uTAE50SyYgy Learn, Network and Connect over two jam-packed days with 500+ industry leaders and gain valuable insights into the future landscape of biotech. Stay Updated on all our events by following Fierce Life Sciences Events #FierceBiotechSummit #WeAreFierce #FierceBiotech #FierceBiotechSummit #BiotechInnovation #LifeSciences #PharmaIndustry #BiotechLeaders #Biotech2024 #BiotechTrends

Join Ed Harnaga from Pfizer at the upcoming Fierce Biotech Summit on Sept 30 - Oct 1 in Boston as he shares his expertise in groundbreaking biotech innovations and advancements. Register now and save up to $500 with the Early Bird Rate: https://ow.ly/uTAE50SyYgy Learn, Network and Connect over two jam-packed days with 500+ industry leaders and gain valuable insights into the future landscape of biotech. Stay Updated on all our events by following Fierce Life Sciences Events #FierceBiotechSummit #WeAreFierce #FierceBiotech #FierceBiotechSummit #BiotechInnovation #LifeSciences #PharmaIndustry #BiotechLeaders #Biotech2024 #BiotechTrends

CEBioForum 2024 Last year at the Polonium Foundation meeting in Paris I had a chance to get to know the BioForum Director Magdalena Kulczycka,Ph.D. Today I had a real pleasure to participate in the Central European BioForum meeting in Warsaw, in short: a networking meeting for biotech companies, start-ups, research institutes. It gave me a new biotechnological perspective on the drug design and clinical trials business. If you have never participated, I guess you can count for the CEBioForum 2025 edition, it's an ongoing event since 2000. The goal is also ongoing: how to enable the biotech lab innovation to get to the market.

?? Exciting insights from Labiotech.eu on the top 10 pharma and biotech venture capital arms! These VC arms are driving innovation by investing in transformative therapeutics and cutting-edge technologies. Highlights include AbbVie Ventures' focus on oncology and neuroscience, JJDC's broad pharmaceutical and medtech investments, and Leaps by Bayer's mission to tackle global challenges. Other key players like Pfizer Ventures and Novartis Venture Fund are also making significant contributions to the biotech ecosystem. Read more to discover how these firms are shaping the future of healthcare and biotechnology: https://lnkd.in/eBF5Xx8w ????

Listen to my colleague Michael J. Tarlov describe the development of the National Institute of Standards and Technology (NIST) Biomanufacturing Program, which provides the #biopharmaceutical and #biotech sectors with measurements and reference materials for their processes and product quality assurance. https://lnkd.in/eV--AAij

??You are working with #antibodies, no matter what shape or complexity? You are looking to submit your #IND? Don't look further as Menarini Biotech can guide you from bench to clinic, from gene to vial. ???? Join our discussion at Medicon Valley Alliance with out top Menarini Biotech experts. And what better way to have great discussions than over fresh coffee and delicious croissants? ??? Let's connect, share ideas, and unlock the future of biotech together! ????

Chicago's climb to 9th place in GEN's Top Biopharma Clusters list underscores our city's growing magnetism for life sciences innovation and company expansion. We're seeing more biotech firms choosing Chicago for their growth, attracted by our world-class research institutions, skilled workforce, and supportive ecosystem. This ranking reflects the hard work of our community and signals to the industry that Chicago is not just a place for startups, but a prime location for established companies to scale and thrive